ArticleBMJ open2025
Adaptive coping mechanisms use and associated factors among adult glaucoma patients attending the University of Gondar Comprehensive Specialized Hospital, Tertiary Eye Care and Training Center, Northwest Ethiopia: an institution-based cross-sectional study.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAdaptive coping mechanisms (ACMs) are effective ways to cope with stress and anxiety in patients with chronic illnesses, such as glaucoma. This study aimed to assess the proportion of ACM and associated factors among adult glaucoma patients enrolled at the tertiary eye care and training centre in Northwest Ethiopia.
designAn institution-based cross-sectional study.
settingThis study was conducted at a tertiary eye care and training centre in Northwest Ethiopia from 15 May 2022 to 30 June 2022.
participantsThe study included a sample of 398 adult glaucoma patients selected using a systematic random sampling technique. PRIMARY AND SECONDARY OUTCOME MEASURES: The participants were diagnosed with glaucoma by ophthalmologists. Optometrists conducted interviews, reviewed medical records and administered a pretested, structured questionnaire based on the Brief Coping Orientation to Problems Experienced inventory. Binary logistic regression was performed to identify associated factors, with significance considered at a p<0.05 and 95% CI.
resultsThe prevalence of ACM use among glaucoma patients was 45.7% (95% CI 41.2% to 50.3%). Factors significantly associated with ACM included urban residence (adjusted OR, AOR 2.57, 95% CI 1.25 to 5.28), higher average family monthly income (AOR 3.83, 95% CI 1.37 to 10.70), moderate to severe visual impairment (AOR 2.24, 95% CI 1.06 to 4.74), duration of diagnosis between 11 and 16 months (AOR 3.94, 95% CI 1.84 to 8.44) and more than 24 months (AOR 3.75, 95% CI 1.59 to 8.81) and the presence of ocular comorbidities (AOR 4.28, 95% CI 2.28 to 8.05).
conclusionsAbout half of adult glaucoma patients used ACM to manage their condition. Older age, urban residence, higher average family monthly income, moderate to severe visual impairment and the presence of ocular comorbidities were significantly associated with ACM. Implementing an integrated approach that incorporates biopsychosocial strategies aimed at reducing ACM and promoting the adaptive one is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.